Get startedLog in
    Picture of Meditera Tibbi Malzeme Sanayi ve Ticaret AS logo

    MEDTR.E — Meditera Tibbi Malzeme Sanayi ve Ticaret AS Cashflow Statement

    0.000.00%
    tr flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapFalling Star
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Meditera Tibbi Malzeme Sanayi ve Ticaret AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    R2022
    December 31st
    R2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line60.416811437.470.3
    Depreciation
    Non-Cash Items4.49-11365.5636425
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-3.68-29.8-56512079.1
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities73.336.6-335869663
    Capital Expenditures-21.4-9.23-92-300-201
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-1.122.911.4417361
    Sale of Fixed Assets
    Change in Net Investments
    Other Investing Cash Flow
    Cash from Investing Activities-22.5-6.33-80.6117160
    Financing Cash Flow Items-3.153.72-11.8-222-205
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-1.03175-130-521-231
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash49.7205-546465592